Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.
Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinical...
Enregistré dans:
Auteurs principaux: | Beatrice Bachmeier, Iduna Fichtner, Peter H Killian, Emanuel Kronski, Ulrich Pfeffer, Thomas Efferth |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2440a68bebd4698b08b8cc0c323a8d9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Internalized Nanoceria Modify the Radiation-Sensitivity Profile of MDA MB231 Breast Carcinoma Cells
par: Emory Bibb, et autres
Publié: (2021) -
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
par: Neelam Mishra, et autres
Publié: (2021) -
Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
par: Buchegger,Kurt, et autres
Publié: (2016) -
Isolation of Breast Cancer Stem Cell from MDA-MB231 Cell Line Using Vincristine
par: Ghanbari,Tara, et autres
Publié: (2016) -
An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231)
par: Gurunathan S, et autres
Publié: (2014)